Search research articles
Contact Us
Filters
Showing results (61-70 of 144) with videos related to
Page
of 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 20, 2005
Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note
Anton J Bilchik, Graeme Poston, Steven A Curley, et al.
Plos Medicine
|
March 3, 2006
Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease
Michael Zeisberg, Mona Khurana, Velidi H Rao, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 21, 2010
Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinoma
Franck Bonnetain, Laetitia Dahan, Emilie Maillard, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
July 12, 2008
Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials
Franck Bonnetain, Xavier Paoletti, Sandra Collette, et al.
Hepato-Gastroenterology
|
September 19, 2009
Prognostic factor of recurrence for resected digestive endocrine tumors
Mehdi Ouaïssi, Catherine Julié, Emmanuel Mitry, et al.
BMC Cancer
|
April 16, 2009
Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study
Jean-Luc Raoul, Jean-Luc Van Laethem, Marc Peeters, et al.
Gastroenterologie Clinique Et Biologique
|
March 2, 2005
Postoperative chemoradiotherapy after surgical resection of gastric adenocarcinoma: can LV5FU2 reduce the toxic effects of the MacDonald regimen? A report on 23 patients
Laetitia Dahan, Dan Atlan, Olivier Bouché, et al.
Gastroenterologie Clinique Et Biologique
|
August 24, 2002
[5-FU, folinic acid and cisplatin (LV5FU2-P) for unresectable pancreatic cancer]
Julien Taïeb, Thierry Lecomte, Joël Ezenfis, et al.
Journal of Hepatology
|
December 28, 2011
Identification of molecular pathways involved in oxaliplatin-associated sinusoidal dilatation
Julie Agostini, Stéphane Benoist, Marie Seman, et al.
Cancer Chemotherapy and Pharmacology
|
April 6, 2010
Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer
Emmanuel Mitry, Pascal Hammel, Gaël Deplanque, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 144) with videos related to
Sort By:
Page
of 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 20, 2005
Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note
Anton J Bilchik, Graeme Poston, Steven A Curley, et al.
Plos Medicine
|
March 3, 2006
Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease
Michael Zeisberg, Mona Khurana, Velidi H Rao, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 21, 2010
Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinoma
Franck Bonnetain, Laetitia Dahan, Emilie Maillard, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
July 12, 2008
Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials
Franck Bonnetain, Xavier Paoletti, Sandra Collette, et al.
Hepato-Gastroenterology
|
September 19, 2009
Prognostic factor of recurrence for resected digestive endocrine tumors
Mehdi Ouaïssi, Catherine Julié, Emmanuel Mitry, et al.
BMC Cancer
|
April 16, 2009
Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study
Jean-Luc Raoul, Jean-Luc Van Laethem, Marc Peeters, et al.
Gastroenterologie Clinique Et Biologique
|
March 2, 2005
Postoperative chemoradiotherapy after surgical resection of gastric adenocarcinoma: can LV5FU2 reduce the toxic effects of the MacDonald regimen? A report on 23 patients
Laetitia Dahan, Dan Atlan, Olivier Bouché, et al.
Gastroenterologie Clinique Et Biologique
|
August 24, 2002
[5-FU, folinic acid and cisplatin (LV5FU2-P) for unresectable pancreatic cancer]
Julien Taïeb, Thierry Lecomte, Joël Ezenfis, et al.
Journal of Hepatology
|
December 28, 2011
Identification of molecular pathways involved in oxaliplatin-associated sinusoidal dilatation
Julie Agostini, Stéphane Benoist, Marie Seman, et al.
Cancer Chemotherapy and Pharmacology
|
April 6, 2010
Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer
Emmanuel Mitry, Pascal Hammel, Gaël Deplanque, et al.
Page
of 15